Re: important-- turning her2+ Stage IV into chronic treatable disease
Immunotherapy is pretty expensive. It is very individualized in many cases. Treatments on the order of $100,000 for cell derived therapies using the patient's cells are common place. I asked for the ability to reduce the cost by 75%, ie get it to $25,000 per patient dose. The client company said they did not think that was possible. Still not sure it is. TDM-1 is $23,000 per dose list price at the hospital. That is a lot for insurance companies to handle. I do not want to go back to the 1950s when cutting was the only option and death was going to occur to disfigured people. I think we need to educate people to think and get meds to be like the computer industry. Get costs down and make healthcare better.
|